文献速递消化道肿瘤与早癌消化内镜

腺瘤检出率提升与间期结直肠癌发生率下降的关联

Association between improved adenoma detection rates and interval colorectal cancer rates after a quality improvement program.
PubMed 文献 · Gastrointest Endosc · 2020-02-21

该回顾性队列研究纳入2003年至2015年在一家学术医学中心接受结肠镜检查的患者,共193,939例次,识别出186例间期结直肠癌(iCRC)。研究显示,内镜医师腺瘤检出率(ADR)最高四分位组患者的iCRC风险显著低于最低四分位组,且2010年启动结肠镜质量改进项目后,总体iCRC率和早期iCRC率均下降。

要点

  • ADR最高四分位(34%-52%)组患者iCRC风险比最低四分位(12%-21%)组低约4倍。
  • iCRC率可作为衡量结肠镜质量的可行、以结局为导向的机构指标。

核心结论

  • iCRC发生率与内镜医师ADR呈负相关;随质量改进项目实施,ADR提高且iCRC率下降。
  • iCRC率测量可考虑作为结肠镜质量的可行、以结局为导向的机构指标。

研究设计与样本

  • 回顾性队列研究,纳入2003年1月至2015年12月在一家学术医学中心接受结肠镜检查的患者。
  • 共193,939例次结肠镜检查,识别出186例iCRC患者。
  • iCRC定义为指数结肠镜检查后6至60个月诊断的癌症,早期iCRC定义为6至36个月诊断的癌症。

关键数值与推荐

  • iCRC定义:指数结肠镜检查后6至60个月诊断的癌症;早期iCRC:6至36个月。
  • ADR最高四分位为34%-52%,最低四分位为12%-21%。

临床怎么用

  • 关注内镜医师ADR作为结肠镜质量指标,并可通过质量改进项目提升ADR以降低iCRC风险。
  • 质量改进措施包括分次剂量肠道准备、质量指标测量、医师教育与反馈。
  • 可考虑将iCRC率作为机构结肠镜质量监测指标。

局限性

  • 为单中心回顾性队列研究,结果外推需谨慎。
  • 原文未报告质量改进项目以外其他混杂因素的控制情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Although colonoscopy reduces colorectal cancer (CRC) risk, interval CRCs (iCRCs) still occur. We aimed to determine iCRC incidence, assess the relationship between adenoma detection rates (ADRs) and iCRC rates, and evaluate iCRC rates over time concomitant with initiation of an institutional colonoscopy quality improvement (QI) program. METHODS: We performed a retrospective cohort study of patients who underwent colonoscopy at an academic medical center (January 2003 to December 2015). We identified iCRCs through our data warehouse and reviewed charts to confirm appropriateness for study inclusion. iCRC was defined as a cancer diagnosed 6 to 60 months and early iCRC as a cancer diagnosed 6 to 36 months after index colonoscopy. We measured the relationship between provider ADRs and iCRC rates and assessed iCRC rates over time with initiation of a QI program that started in 2010. RESULTS: A total of 193,939 colonoscopies were performed over the study period. We identified 186 patients with iCRC. The overall iCRC rate was .12% and the early iCRC rate .06%. Average-risk patients undergoing colonoscopy by endoscopists in the highest ADR quartile (34%-52%) had a 4-fold lower iCRC risk (relative risk, .23; 95% confidence interval, .11-.48) than those undergoing colonoscopy by endoscopists in the lowest quartile (12%-21%). After QI program initiation, overall iCRC rates improved from .15% to .08% (P < .001) and early iCRC rates improved from .07% to .04% (P = .004). CONCLUSIONS: We confirmed that iCRC rate is inversely correlated with provider ADR. ADRs increased and iCRC rates decreased over time, concomitant with a QI program focused on split-dose bowel preparation, quality metric measurement, provider education, and feedback. iCRC rate measurement should be considered a feasible, outcomes-driven institutional metric of colonoscopy quality.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Lam AY, Li Y, Gregory DL, et al. Association between improved adenoma detection rates and interval colorectal cancer rates after a quality improvement program. Gastrointest Endosc. 2020. PMID: 32092289. doi:10.1016/j.gie.2020.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。